Angiotensin-(1–7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism
- 5 November 2014
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 128 (5), 307-319
- https://doi.org/10.1042/cs20140215
Abstract
Skeletal muscle atrophy is a pathological condition characterized by the loss of strength and muscle mass, an increase in myosin heavy chain (MHC) degradation and increase in the expression of two muscle-specific ubiquitin ligases: atrogin-1 and MuRF-1. Angiotensin II (AngII) induces muscle atrophy. Angiotensin-(1-7) [Ang-(1-7)], through its receptor Mas, produces the opposite effects than AngII. We assessed the effects of Ang-(1-7) on the skeletal muscle atrophy induced by AngII. Our results show that Ang-(1-7), through Mas, prevents the effects induced by AngII in muscle gastrocnemius: the decrease in the fibre diameter, muscle strength and MHC levels and the increase in atrogin-1 and MuRF-1. Ang-(1-7) also induces AKT phosphorylation. In addition, our analysis in vitro using C2C12 myotubes shows that Ang-(1-7), through a mechanism dependent on Mas, prevents the decrease in the levels of MHC and the increase in the expression of the atrogin-1 and MuRF-1, both induced by AngII. Ang-(1-7) induces AKT phosphorylation in myotubes; additionally, we demonstrated that the inhibition of AKT with MK-2206 decreases the anti-atrophic effects of Ang-(1-7). Thus, we demonstrate for the first time that Ang-(1-7) counteracts the skeletal muscle atrophy induced by AngII through a mechanism dependent on the Mas receptor, which involves AKT activity. Our study indicates that Ang-(1-7) is novel molecule with a potential therapeutical use to improve muscle wasting associated, at least, with pathologies that present high levels of AngII.Keywords
This publication has 63 references indexed in Scilit:
- The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscleMolecular and Cellular Endocrinology, 2013
- Impact of angiotensin II on skeletal muscle metabolism and function in mice: Contribution of IGF-1, Sirtuin-1 and PGC-1αActa Histochemica, 2013
- Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteinsAmerican Journal of Physiology-Cell Physiology, 2011
- Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cellsBiochemical and Biophysical Research Communications, 2011
- Angiotensin II receptor type 1 blockade decreases CTGF/CCN2‐mediated damage and fibrosis in normal and dystrophic skeletal musclesJournal of Cellular and Molecular Medicine, 2011
- Targeting the angiotensin pathway in idiopathic pulmonary fibrosisEmerging Therapeutic Targets, 2008
- Oxidative stress in hypertension and chronic kidney disease: role of angiotensin IISeminars in Nephrology, 2004
- Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockadeAmerican Journal of Physiology-Renal Physiology, 2003
- Angiotensin II and Cardiac FibrosisTrends in Cardiovascular Medicine, 1996
- Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.JCI Insight, 1996